iPS膵島 糖尿病治験へ使う 「１型」に有効 来年にも 京大病院で開始か インスリン注射が 不要となる
According to the sources familiar with the matter, Hospital at Kyoto University is planning to start the new treatment method for type 1 diabetes using iPS cells (induced pluripotent cells). Type 1 diabetes is caused from malfunctions of pancreas. Through this treatment the patients could reduce their burden like there is no need for insulin injection. This new way of treatment also will prevent the patients from dying from low blood sugar. The new treatment will start next year at the earliest. They are planning to get this method in practice in many other medical facilities starting in 2030 after experiments in related firms.
According to the sources familiar with the matter, Hospital at Kyoto University is planning to start the new treatment method for type 1 diabetes using iPS cells (induced pluripotent cells). Type 1 diabetes is caused from malfunctions of pancreas. Through this treatment the patients could reduce their burden like there is no need for insulin injection. This new way of treatment also will prevent the patients from dying from low blood sugar. The new treatment will start next year at the earliest. They are planning to get this method in practice in many other medical facilities starting in 2030 after experiments in related firms.
